Skip to content

Comparison of the effect of lidocaine on gallbladder bed after cholecystectomy and lidocaine at the port site before surgery in the control of pain after laparoscopic cholecystectomy

Comparison of the effect of lidocaine on gallbladder bed after cholecystectomy and lidocaine at the port site before surgery in the control of pain after laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191104045328N4
Enrollment
82
Registered
2020-04-29
Start date
2019-12-22
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic cholecystectomy. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: In group A, patients will receive a 2% lidocaine ampoule using a laparoscope after preparation for surgery and placement of the laparoscopic ports and removal of th

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients Candidate for Cholecystectomy Referred to Vali Asr Hospital ASA Class 2 and 3 Operation by a resident and surgeon No Lidocaine Allergy

Exclusion criteria

Exclusion criteria: Lidocaine contraindications such as complete heart block, severe hypotension and shock History of specific illnesses such as kidney, liver and heart problems Patients with a history of drug abuse

Design outcomes

Primary

MeasureTime frame
Pain Score. Timepoint: 24 hours after surgery. Method of measurement: Visual acuity scale.;Frequency of analgesic use. Timepoint: During the first 24 hours of hospitalization. Method of measurement: number.;The number of days the bowel sound returned. Timepoint: During hospitalization. Method of measurement: check list.;Time elapsed until return to oral diet. Timepoint: During hospitalization. Method of measurement: check list.;Duration of hospitalization. Timepoint: During hospitalization. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Amir Reza Naeimi

Arak University of Medical Sciences

naeemi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026